Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,972 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Left Ventricular Longitudinal Myocardial Function of Heart Failure Patients With Transition From Reduced to Preserved Ejection Fraction and of Those With Preserved Ejection Fraction.
Nagai S, Nishimori M, Kintsu M, Todo S, Ota E, Odajima S, Takeuchi K, Ichikawa Y, Yamauchi Y, Shiraki H, Yamashita K, Fukuda T, Hisamatsu E, Hirata KI, Tanaka H. Nagai S, et al. Among authors: fukuda t. Circ Rep. 2024 Apr 13;6(5):161-167. doi: 10.1253/circrep.CR-24-0025. eCollection 2024 May 10. Circ Rep. 2024. PMID: 38736842 Free PMC article.
Identification of factors associated with progression of left atrial enlargement in patients with atrial fibrillation.
Uemura K, Nishimori M, Nagai S, Takeuchi M, Nishihara Y, Todo S, Oota E, Odajima S, Takeuchi K, Ichikawa Y, Kintsu M, Yamauchi Y, Shiraki H, Yamashita K, Fukuda T, Hisamatsu E, Hirata KI, Tanaka H. Uemura K, et al. Among authors: fukuda t. Echocardiography. 2023 Sep;40(9):976-982. doi: 10.1111/echo.15666. Epub 2023 Aug 1. Echocardiography. 2023. PMID: 37526563
Left ventricular reverse remodeling following initiation of sacubitril/valsartan for heart failure with reduced ejection fraction and low blood pressure.
Nishihara Y, Nishimori M, Sawa T, Uemura K, Nagai S, Todo S, Oota E, Odajima S, Takeuchi K, Ichikawa Y, Kintsu M, Yamauchi Y, Shiraki H, Yamashita K, Fukuda T, Hisamatsu E, Shimizu M, Hirata KI, Tanaka H. Nishihara Y, et al. Among authors: fukuda t. Heart Vessels. 2024 Feb;39(2):95-104. doi: 10.1007/s00380-023-02311-3. Epub 2023 Sep 21. Heart Vessels. 2024. PMID: 37733071
Overview of the 88th Annual Scientific Meeting of the Japanese Circulation Society (JCS2024)　- The Future of Cardiology - Challenges in Overcoming Cardiovascular Disease.
Tanaka H, Ishida T, Emoto T, Nagao M, Izawa Y, Fukuda T, Toba T, Hisamatsu E, Taniguchi Y, Imamura K, Takami M, Kawamori H, Otake H, Fukuzawa K, Toh R, Satomi-Kobayashi S, Yamashita T, Hirata KI. Tanaka H, et al. Among authors: fukuda t. Circ J. 2024 Aug 23;88(9):1502-1508. doi: 10.1253/circj.CJ-24-0503. Epub 2024 Jul 18. Circ J. 2024. PMID: 39019582 Free article.
Low survival due to higher risk of relapse and non-relapse mortality after allogeneic HSCT in ATL compared with AML and ALL.
Tomori S, Morishima S, Kato K, Nakasone H, Nakano N, Eto T, Kawakita T, Suehiro Y, Miyazaki Y, Uchida N, Sawayama Y, Mori Y, Nakamae H, Nagafuji K, Uehara Y, Doki N, Kanda J, Fukuda T, Atsuta Y, Yoshimitsu M; JSTCT ATL Working Group and JSTCT Transplant Complications Working Group. Tomori S, et al. Among authors: fukuda t. Transplant Cell Ther. 2025 Jan 17:S2666-6367(25)00909-1. doi: 10.1016/j.jtct.2025.01.882. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39828057
Phase 1 Study of Quercetin, a Natural Antioxidant in Children and Young Adults with Fanconi Anemia (FA).
Mehta PA, Nelson AS, Loveless SK, Lane A, Fukuda T, Teusink-Cross A, Elder D, Lagory D, Miller E, Cancelas JA, Howell J, Zhao J, Mizuno K, Myers KC, Lake K, McIntosh K, Setchell KDR, Luebbering N, Edwards S, Chihanga T, Wells SI, Davies SM. Mehta PA, et al. Among authors: fukuda t. Blood Adv. 2025 Jan 16:bloodadvances.2024015053. doi: 10.1182/bloodadvances.2024015053. Online ahead of print. Blood Adv. 2025. PMID: 39820512
4,972 results